Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This study is to assess the Sirolimus Tablets 2 mg of Dr. Reddy's Laboratories Limited, India
and Rapamune® (Sirolimus) tablets 2 mg of Wyeth Laboratories, Philadelphia in healthy,
adult,human subjects under Fasting conditions.